Subscriptions & membership

With access to the latest news, specialist articles, company information and events, we make becoming an industry “thought leader” simple. We also offer great deals for members who want to promote their company, and for multi-user packages.

Choose your membership category below and experience for yourself why thousands of pharmaceutical and life science professionals have already become members of the European Pharmaceutical Review community.

Extra savings!

Group/company subscriptions are also available at a discounted rate. We also offer a multi-year pricing option. Please contact us for more details.

European Pharmaceutical Review provides well balanced and up-to-date information to the pharmaceutical scientist. I like the fact that it tackles complicated issues and technologies and presents them in a rigorous and comprehensive way.

Dr. E. Freire
Professor
Johns Hopkins University, U.S.

Platinum subscription

2 year subscription to European Pharmaceutical Review

Just £135 - save 25%

Subscribe now >>

  • Receive the next 12 issues of European Pharmaceutical Review magazine
  • Online access to the latest issue and over 400 articles from the European Pharmaceutical Review back issue archive
  • Receive European Pharmaceutical Review's bi-weekly email newsletter

Gold
subscription

1 year subscription to European Pharmaceutical Review

£90 per annum

Subscribe now >>

  • Receive the next 6 issues of European Pharmaceutical Review magazine
  • Online access to the latest issue and over 400 articles from the European Pharmaceutical Review back issue archive
  • Receive European Pharmaceutical Review's bi-weekly email newsletter

Silver
membership

1 year access to every issue online

£30 per annum

Join now >>

  • Online access to the latest issue and over 400 articles from the European Pharmaceutical Review back issue archive
  • Receive European Pharmaceutical Review's bi-weekly email newsletter

Bronze membership

Access to back issue articles more than a year old

Limited access - Free

Join now >>

  • Gain access to back issue articles more than a year old
  • Receive European Pharmaceutical Review's bi-weekly email newsletter